Cargando…
Drug-induced dyspnea versus cystic fibrosis exacerbation: a diagnostic dilemma
Cystic fibrosis (CF) is a disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator protein in the epithelial membrane, and affects at least 30,000 people in the USA. There are between 900 and 1000 new cases diagnosed every year. Traditionally, CF has been treated sympt...
Autores principales: | Walayat, Saqib, Hussain, Nooreen, Patel, Jaymon, Hussain, Faiz, Patel, Preeti, Dhillon, Sonu, Aulakh, Bhagat, Chittivelu, Subramanyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529089/ https://www.ncbi.nlm.nih.gov/pubmed/28769592 http://dx.doi.org/10.2147/IMCRJ.S139022 |
Ejemplares similares
-
A devastating cardiovascular event in an adult cystic fibrosis patient: An unforeseen outcome of increasing life expectancy
por: Hussain, Nooreen, et al.
Publicado: (2018) -
A diagnosis of late-onset Myasthenia gravis unmasked by topical antibiotics
por: Hussain, Nooreen, et al.
Publicado: (2018) -
Invasive meningococcal disease without meningitis: a forgotten diagnosis
por: Walayat, Saqib, et al.
Publicado: (2018) -
Role of albumin in cirrhosis: from a hospitalist’s perspective
por: Walayat, Saqib, et al.
Publicado: (2017) -
A woman with dyspnea and recurrent pneumothorax: when dyspnea is not asthma
por: Chidharla, Anusha, et al.
Publicado: (2020)